| 000 | 01474 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513095231.0 | ||
| 264 | 0 | _c19960926 | |
| 008 | 199609s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm950538t _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBergmann, K E | |
| 245 | 0 | 0 |
_aQuantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cAug 1996 |
||
| 300 |
_a3394-400 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xmicrobiology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemical synthesis |
| 650 | 0 | 4 | _aEsters |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMycobacterium _xdrug effects |
| 650 | 0 | 4 |
_aMycobacterium Infections _xmicrobiology |
| 650 | 0 | 4 |
_aMycobacterium avium _xdrug effects |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 |
_aPyrazinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTuberculosis _xmicrobiology |
| 700 | 1 | _aCynamon, M H | |
| 700 | 1 | _aWelch, J T | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 39 _gno. 17 _gp. 3394-400 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm950538t _zAvailable from publisher's website |
| 999 |
_c8762369 _d8762369 |
||